“Our nutraceutic will be one of the greatest tuberculosis solutions”: Dr Cardona explained our last adventure at Biocat.cat

Biocat has recently released in their webpage an interview with Dr Cardona, where he answers questions on our last adventure:  Nyaditum resae®. This nutraceutic was born to help in avoiding the disease development in M.tuberculosis-infected people, and it was patented at our Unit and futher fully transferred to Manremyc SL for its commercialization. Biocat is an organization that coordinates and promotes the life sciences sector in Catalonia.

You can access the interview here.

Advertisements
This entry was posted in Uncategorized and tagged , , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s